A case of primary ovarian signet-ring cell carcinoma treated with S-1/CDDP therapy

被引:0
作者
Tadahiro Shoji
Ryosuke Takeshita
Tatsunori Saito
Takeshi Aida
Shunichi Sasou
Tsukasa Baba
机构
[1] Iwate Medical University School of Medicine,Department of Obstetrics and Gynecology
[2] Hachinohe Red Cross Hospital,Department of Obstetrics and Gynecology
[3] Hachinohe Red Cross Hospital,Department of Pathology and Laboratory
来源
Journal of Ovarian Research | / 13卷
关键词
Ovarian cancer; Signet-ring cell carcinoma; S-1; CDDP;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 82 条
[1]  
Su RM(2003)Signet-ring stromal tumor of the ovary: a case report Int J Gynecol Cancer 13 90-93
[2]  
Chang KC(2010)Primary signet ring cell mucinous ovarian carcinoma: a case report and literature review Case Rep Oncol 3 451-457
[3]  
Chou CY(2012)A case of primary signet ring cell carcinoma of the ovary The J Fukuoka College Obstet Gynecol 36 13-16
[4]  
El-Safadi S(2014)Primary ovarian mucinous carcinoma with signet ring cells - report of a rare case J Clin Diagn Res 8 FD12-FD13
[5]  
Stahl U(2018)Primary ovarian signet ring cell carcinoma: a rare case report Mol Clin Oncol 9 211-214
[6]  
Tinneberg HR(2003)Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a gynecologic oncology group study J Clin Oncol 21 3194-3200
[7]  
Hackethal A(2003)Arbeitsgemeinschaft Gynäkologische Onkologie ovarian Cancer study group. A randomized clinical trial of cisplatin/paclitaxel versus carboplatin/paclitaxel as first-line treatment of ovarian cancer J Natl Cancer Inst 95 1320-1329
[8]  
Muenstedt K(1896)Uber das fibrosarcoma ovarii mucocellulare (carcinomatodes) Arch Gynecol 50 287-321
[9]  
Ogawa S(1968)Primary Krukenberg tumor of ovary. Review of literature and case report Cancer 22 1199-1207
[10]  
Inoue S(1996)Development of a novel form of an oral 5-fluorouracil derivative (S-1) directed to the potentiation of the tumor selective cytotoxicity of 5-fluorouracil by two biochemical modulators Anti-Cancer Drugs 7 548-557